Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ:307750)
South Korea · Delayed Price · Currency is KRW 1,957.00
-78.00 (-3.83%)
At close: Jul 28, 2026
Kookjeon Pharmaceutical Market Cap
Kookjeon Pharmaceutical has a market cap or net worth of 105.65 billion as of July 28, 2026. Its market cap has decreased by -50.31% in one year.
Market Cap
105.65B
Enterprise Value
116.69B
Revenue
127.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,957.00
ChartMarket Cap Chart
Since December 16, 2020, Kookjeon Pharmaceutical's market cap has increased from 37.63B to 105.65B, an increase of 180.80%. That is a compound annual growth rate of 20.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 105.65B | -37.43% |
| Dec 30, 2025 | 168.84B | -2.11% |
| Dec 30, 2024 | 172.48B | -43.67% |
| Dec 28, 2023 | 306.19B | -5.74% |
| Dec 29, 2022 | 324.84B | -39.54% |
| Dec 30, 2021 | 537.31B | 40.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agabang&Company | 113.32B |
| RS Automation | 113.32B |
| Green Resource | 113.30B |
| Suprema HQ | 113.27B |
| ABOV Semiconductor | 112.85B |
| KX Innovation | 112.72B |
| Genexine | 112.56B |
| Deutsch Motors | 112.18B |